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A Lymantria dispar nuclear polyhedrosis virus (LdMNPV) gene has been identified that encodes a homolog
to the granulovirus (GV) enhancin proteins that are capable of enhancing the infection of other baculoviruses.
Enhancin genes have been identified and sequenced for three species of GVs but have not been found in any
other nuclear polyhedrosis virus to date. The LdMNPV enhancin gene is located between 67.6 and 70.1 kbp on
the viral genome. Northern and primer extension analyses of viral RNAs indicate that the enhancin gene
transcripts are expressed at late times postinfection from a consensus baculovirus late promoter. The LdMNPV
enhancin exhibits 29% amino acid identity to the enhancin proteins of the Trichoplusia ni, Pseudaletia unipuncta,
and Helicoverpa armigera GVs. All four proteins contain a conserved zinc-binding domain characteristic of
metalloproteases. A recombinant virus (enhancin::cat) was constructed in which the LdMNPV enhancin gene
was inactivated by insertion mutagenesis in order to ascertain the effect of the enhancin protein on viral
potency. The bioassay results indicate that disruption of the enhancin gene in the LdMNPV results in a
reduction in viral potency.
Nuclear polyhedrosis virus (NPVs) and granuloviruses
(GVs) are members of the Baculoviridae which infect insects
and other arthropods. All baculoviruses have a unique infec-
tion cycle in that they produce two infectious forms: a budded
virus, which infects different cell types within a single larva; and
an occlusion body, a form of the virus that is embedded in a
protein structure. Larvae are infected upon ingestion of the
occlusion body and release of the viral particles in the alkaline
environment of the midgut. In NPVs, many viral particles are
occluded in a single intranuclear crystal called a polyhedron,
whereas in GVs a single viral particle is found in each crystal,
or granule. The polyhedron protects the viral particles from
environmental elements and is the viral form that is used for
biocontrol of agricultural and forest insect pests (for a review
see reference 10).
Enhancin, which has also been referred to as the synergistic
or viral enhancing factor, is a protein found in the GV occlu-
sion body that has the ability to enhance the infection of other
NPVs (15, 18, 37, 40, 41). The enhancin protein is highly
expressed in GVs and makes up approximately 5% of the total
protein in the granules (37). It has been localized deep within
the capsule matrix, close to the viral envelope (47, 49). Purified
enhancin from the Trichoplusia ni GV (TnGV) can enhance
the infection of the Autographa californica NPV (AcMNPV) 2-
to 4-fold when fed to T. ni larvae and up to 12-fold when fed
to other larvae such as those of Spodoptera exigua (45). Re-
cently, enhancin genes have also been identified in the Pseu-
daletia unipuncta GV (PuGV) and the Helicoverpa armigera
GV (HaGV) (32).
Two modes of action have been observed for enhancin pro-
teins. First, the enhancins exhibit proteolytic activity (16, 38)
which results in the enzymatic hydrolysis of the peritrophic
membrane (12, 45), a barrier against microbial pathogens in
the insect midgut. Degradation of the peritrophic membrane
by enhancin is believed to allow the virus easier access to the
midgut columnar cells, resulting in the insect’s increased sus-
ceptibility to viral infection (12). Second, there is an increased
fusion of the nucleocapsids with the midgut cells through in-
teraction of the enhancin protein with both the viral envelope
and the cell plasma membrane (37, 39, 42, 45).
The Lymantria dispar NPV (LdMNPV) is pathogenic to the
gypsy moth, a forest and urban tree-defoliating pest in the
northeastern United States. The genome of the LdMNPV is
approximately 162 kbp in length (29), in contrast to the 133-
kbp genome of the prototype baculovirus, AcMNPV. The en-
tire genome of the AcMNPV has been sequenced (2), and
although that of the LdMNPV is not as well characterized,
several genes which are present in both the LdMNPV and the
AcMNPV have been identified (6, 9, 31, 36). The extra 29 kbp
of DNA present in the LdMNPV suggests that this virus has
the potential to possess several genes which are not present in
the AcMNPV. Two genes, the host range factor 1 gene (43)
and G22 (5), that have been identified and characterized for
the LdMNPV do not have homologs in the AcMNPV. In this
study we extended the characterization of the LdMNPV by
cloning and sequencing the enhancin gene. Homologs of this
gene are present in the GVs but have not been identified in
any other NPV to date. We also explored the effect of the
LdMNPV enhancin protein on viral pathogenicity by inactivat-
ing the enhancin gene through insertional mutagenesis.
MATERIALS AND METHODS
Cells, virus, and insects. L. dispar 652Y cells were grown as monolayers in
Goodwin’s IPL-52B medium supplemented with 6.25 mM glutamine and 10%
fetal bovine serum. Cell cultures were inoculated with either LdMNPV isolate
A21-MPV (35), which produces wild-type polyhedra, or the enhancin::cat virus
(in which enhancin is disrupted by a chloramphenicol acetyltransferase [cat]
gene). L. dispar egg masses were obtained from the U.S. Department of Agri-
culture’s Animal and Plant Health Inspection Service rearing facility at Otis Air
Force Base (Mass.). Hatched larvae were reared on a gypsy moth diet (3).
Viral DNA isolation and Southern blot analysis. Budded virus was isolated
from infected 652Y cells as described previously (4) and used as a source of
genomic DNA for restriction analysis. Viral DNA was digested with restric-
tion endonucleases and fractionated on 1.0% agarose–Tris-borate-EDTA
gels. Southern blot analysis was performed on nitrocellulose with probes labeled
with the nick translation kit (Bethesda Research Laboratories) and [a-32P]dCTP
(NEN).
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Sequencing. The sequence of the enhancin gene from isolate A21-MPV was
determined for both strands by the dideoxynucleotide sequencing method. Plas-
mid and single-strand M13 DNA templates were sequenced with the Sequenase
version 2.0 DNA sequencing kit (U.S. Biochemicals) or the fmol DNA sequenc-
ing system (Promega) by using the protocols supplied with the kits. a-35S-dATP
was supplied by NEN. Sequence analysis was done with the MacVector program
(International Biotechnologies, Inc.).
In vitro transcription and translation of the enhancin gene. A 4.2-kbp SstII
fragment containing the enhancin gene was subcloned into pBluescript SK1
(Stratagene) to generate pDB126. The enhancin protein was expressed from
pDB126 with the TNT coupled reticulocyte lysate system and T7 RNA polymer-
ase (Promega) per the directions provided with the kit. The expressed protein
was labeled by the addition of [35S]methionine (NEN). Reaction products were
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and autoradiography.
RNA isolation and Northern blot analysis. A21-MPV-infected 652Y cells were
harvested at various times postinfection (p.i.). Cytoplasmic RNA was isolated as
described by Friesen and Miller (14). RNA was separated on 1.2% agarose gels
containing formaldehyde and transferred to nitrocellulose. Northern blot anal-
ysis was performed as described by Mahmoudi and Lin (28). A 30-base oligo-
nucleotide (complementary to positions 939 to 968 in Fig. 2) was end labeled
with [g-32P]ATP (NEN) and used as a strand-specific probe to detect the en-
hancin transcripts.
Primer extension mapping of transcripts. Primer extension reactions were
performed by the method of Crawford and Miller (11). Cytoplasmic RNA was
isolated at 48 and 72 h p.i. from 652Y cells infected with A21-MPV. An 18-base
oligonucleotide (complementary to positions 132 to 149 in Fig. 2) was used in the
reactions after being end labeled with [g-32P]ATP (NEN). The primer was
extended with Moloney murine leukemia virus reverse transcriptase. Primer
extension products were fractionated on 6% polyacrylamide–8 M urea gels and
visualized by autoradiography.
Construction of the enhancin::cat virus. A transplacement vector (pDB159)
containing the enhancin gene disrupted with the cat gene was constructed. Trans-
fections were carried out with 2.5 mg of A21-MPV viral DNA and 2.5 mg of
pDB159 plasmid DNA by using the Lipofectin reagent (Bethesda Research
Laboratories) as described previously (6). At 7 days p.i., the cells and medium (3
ml) were collected and diluted with 12 ml of fresh medium in a T75 flask. The
nonoccluded virus was collected at 7 days p.i. and plaque purified. Approximately
200 plaques were picked and used to infect 652Y cells in P96 plates. To identify
recombinant viruses, budded virus (50 ml) from the P96 wells was blotted by
standard techniques and probed with the 0.7-kbp SstI fragment containing the cat
gene from pDB4 (8). For further details, see Results and Discussion.
Bioassay analysis of the enhancin::cat virus. Polyhedra were isolated from
652Y cells infected with either A21-MPV or the enhancin::cat virus and were
purified and quantitated as previously described (34). Fourth-instar L. dispar
larvae were infected per os by placing them on a diet containing surface-applied
in vitro-synthesized polyhedra (total of 5 3 106 polyhedra). The larvae were
placed on fresh food after 48 h on the infected diet. Dead larvae were collected
and used as a source of in vivo polyhedra for the bioassays. The polyhedra were
tested for biological activity by both the diet incorporation (23) and the droplet
feeding (21, 22) methods.
In the diet incorporation bioassays, second-instar larvae were infected by
placing them on a diet containing various concentrations of polyhedra (102 to 107
polyhedra per ml of diet) and allowing them to feed ad libitum for 48 h. Five
groups (20 larvae each) were infected at each virus dose. After 48 h on the diet
containing virus, the larvae were removed and placed on a fresh diet for the
remaining 12 days of the bioassay. This type of bioassay was repeated in tripli-
cate.
In the droplet feeding assay, neonate larvae (60 larvae per dilution) were
allowed to feed for 30 min on droplets containing various dilutions of polyhedra
(5 3 103 to 106 polyhedra per ml of solution). The larvae were then placed on a
fresh diet and were monitored for death for up to 18 days. The volume of
solution ingested by L. dispar neonate larvae in the droplet feeding assay was
determined by the method of Kunimi and Fuxa (26).
Dead larvae from both bioassays were removed and counted daily. The 50%
lethal concentrations (LC50s) and 50% lethal times were determined for each
virus by Probit analysis (13) by using the POLO-PC program (LeOra Software,
Berkeley, Calif. [33]). The 50% lethal times and 50% lethal doses were also
determined for the droplet feeding method by using the ViStat program (version
2.1; Boyce Thompson Institute, Cornell University, Ithaca, N.Y. [20]).
Nucleotide sequence accession number. The nucleotide sequence accession
number of the sequence contained in this paper is AF019971.
RESULTS AND DISCUSSION
Identification of the enhancin gene. The enhancin gene was
identified during the mapping and sequencing of the gene
mutated in LdMNPV few polyhedron mutants. Initially these
mutations were mapped to a 4.3-kbp BamHI/EcoRI fragment
located at 64.5 to 68.9 kbp on the viral genome. Further map-
ping studies revealed that these mutations were within the 25K
FP gene between 65.3 and 66.0 kbp (6, 7). During the sequenc-
ing of the 4.3-kbp fragment, an open reading frame (ORF)
which initiated within this fragment and proceeded through
the EcoRI site located at 68.9 kbp was discovered. The pre-
dicted amino acid sequence of this partial ORF was compared
with those of other proteins in GenBank at the National Cen-
ter for Biotechnology Information by using the BLAST net-
work server (1). This ORF exhibited homology to the enhancin
genes of the TnGV, PuGV, and HaGV. The entire ORF was
subcloned on a 4.2-kbp SstII fragment (67.0 to 71.2 kbp on the
viral genome) into pBluescript SK1 to generate pDB126, and
the DNA sequence of the ORF was determined. The LdM-
NPV enhancin gene is located between 67.6 and 70.1 kbp on
the viral genome and is transcribed clockwise with respect to
the circular viral genome (Fig. 1A). A partial restriction map
and the ORF map of a 2.46-kbp fragment in this region are
presented in Fig. 1B, with the largest ORF (2,346 bp in frame
1) corresponding to the enhancin gene.
Characteristics of the nucleotide sequence. The nucleotide
sequence of the 2,460-bp fragment containing the LdMNPV
enhancin gene is presented in Fig. 2 along with the predicted
amino acid sequence of the protein. The enhancin ORF begins
at nucleotide position 49 and ends at position 2395. The gene
could encode a 782-amino acid (aa) protein with a predicted
molecular mass of 89,200 Da. Analysis of the sequence up-
stream of the enhancin ORF reveals a potential baculovirus
late promoter sequence, TTAAG, beginning 13 bp upstream of
the enhancin start codon (nucleotides 36 to 40 [Fig. 2]). Po-
tential late baculovirus promoter motifs have also been iden-
tified upstream of the enhancin genes in the TnGV (ATAAG
[18]) and the PuGV (ATAAG [32]). In addition, enhancin
FIG. 1. Genomic location of the LdMNPV enhancin gene. (A) BglII restric-
tion map of the LdMNPV viral genome, with the letter designation of each
fragment shown above (6). The locations of other known LdMNPV genes are
also indicated. Abbreviations: polh, polyhedrin gene (36); 25K FP, 25K few
polyhedron gene (6); egt, ecdysteroid UDP-glucosyltransferase gene (31); DNA
pol, DNA polymerase gene (9); hrf-1, host range factor 1 gene (43). (B) The
enlarged map indicates the 2,460-bp fragment that encodes enhancin (67.6 to
70.1 kbp on the viral genome). Restriction sites used in subcloning and sequenc-
ing of the gene are shown. ORF analysis of this fragment is shown in all six
reading frames. The black boxes indicate ORFs encoding sequences that are at
least 25 aa in length and which begin with an ATG start codon as determined by
the MacVector program from International Biotechnologies, Inc. The shaded
box indicates the ORF corresponding to the LdMNPV enhancin gene.
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transcripts have been shown to initiate within the HaGV late
promoter motif TTAAG (at the nucleotides underlined within
this sequence [32]).
Immediately downstream of the LdMNPV enhancin gene is
the hrf-1 gene (43), which is also transcribed in a clockwise
direction (Fig. 1A). There is no potential polyadenylation sig-
nal sequence that can be identified in the 119 bp between the
enhancin stop codon and the hrf-1 start codon. This is similar
to the TnGV, PuGV, and HaGV, which also lack canonical
polyadenylation signal sequences between the enhancin gene
and the downstream gene (ORF1) (18, 32). Despite the simi-
larity between the LdMNPV and the GVs with respect to the
organization of the enhancin gene and its downstream gene
(hrf-1 or ORF1), the LdMNPV hrf-1 gene shows no homology
to the GV ORF1 genes.
Characteristics of the protein sequence. The LdMNPV en-
hancin gene encodes a shorter protein than the GV enhancin
genes, with 782 aa for the LdMNPV enhancin compared to 901
or 902 aa for the GV enhancins. All four proteins show mod-
erate homology at the N terminus and are less homologous at
the C-terminal end (Fig. 3A). The TnGV and PuGV enhancin
proteins are virtually identical, with only 15 residue changes
between the proteins for an overall 98% amino acid identity
(18, 32). The HaGV enhancin protein is less homologous to
the other two GV proteins (TnGV and PuGV), with 81%
amino acid identity (89% over the first 550 aa and 69% over
the last 350 aa) and 90% similarity when conservative resi-
due changes are taken into consideration (Fig. 3B) (32). The
LdMNPV enhancin protein shows approximately 31% amino
acid identity (Fig. 3A) to each of the three GV enhancin
proteins (32.1% to the TnGV protein, 32.2% to the PuGV
protein, and 31.4% to the HaGV protein), with approximately
55% similarity (54.7% to the TnGV protein, 55.2% to the
PuGV protein, and 55.6% to the HaGV protein). Overall the
four proteins exhibit 29% amino acid identity, with four areas
exhibiting greater than 50% amino acid identity (residues 59 to
67 at 78%, 196 to 290 at 51%, 451 to 468 at 58%, and 692 to
704 at 54% [Fig. 3B]).
Comparison of the LdMNPV enhancin amino acid sequence
with sequences in the BLOCKS database (version 9.0, Decem-
ber 1995 [19]) revealed the presence of a signature pattern
characteristic of a zinc-binding domain found within metallo-
proteases (25, 30). The signature pattern, HEXXH, is sufficient
to group a protein into the metalloprotease superfamily. All
four of the enhancin proteins have this conserved metallo-
protease zinc-binding domain (residues 241 to 246 for the
LdMNPV) within a larger region of the protein, and all four
exhibit 51% amino acid identity in this region (residues 196 to
290 [Fig. 3]). For this type of enzyme, the zinc ion is chelated
by the two histidine residues in this sequence and by a third
residue, typically a histidine, cysteine, or aspartic or glutamic
acid residue, located anywhere from 20 to 120 aa downstream
of the HEXXH sequence (for reviews, see references 17 and
24). There are two aspartic acid and two glutamic acid residues
between 20 and 120 aa from the HEXXH sequence which are
conserved in all four enhancin proteins (LdMNPV residues
269, 289, 297, and 302), any of which could function as a
third zinc-binding ligand in the enhancin proteins (Fig. 3A). In
the metalloproteases, the glutamic acid residue within the
HEXXH sequence is the catalytic base which polarizes a water
molecule involved in the nucleophilic attack of the peptide
bond to be cleaved. Recently, it has been demonstrated that
the TnGV enhancin gene encodes a metalloprotease (27) that
is capable of degrading an insect intestinal mucin in the T. ni
larval midgut (46).
In vitro transcription and translation of the enhancin gene.
To demonstrate that the enhancin ORF encoded a protein, the
gene was expressed from pDB126 in a rabbit reticulocyte cou-
pled transcription and translation system. Plasmid pDB126
contains the 4.2-kbp SstII fragment (67.0 to 71.2 kbp on the
viral genome) and has the enhancin gene under the control of
the T7 polymerase. Several radiolabeled bands, with apparent
molecular masses ranging from 25 to 88 kDa, were visualized
after analysis by SDS-PAGE and autoradiography (Fig. 4). The
size of the enhancin protein is predicted to be 89 kDa from the
nucleotide sequence. The smaller bands may correspond to
translation initiation at internal methionine-encoding bases
within the enhancin ORF or could be degradation products of
FIG. 2. Nucleotide sequence of the 2,460-bp fragment containing the
LdMNPV enhancin gene and the predicted amino acid sequence. The consensus
late promoter sequence is shaded, with the late transcriptional start site under-
lined. The SstI restriction endonuclease site used in construction of the enhancin-
::cat virus is boxed. Oligonucleotides used in transcriptional mapping and primer
extension are underlined (see text).
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FIG. 3. Alignment of the enhancin proteins with CLUSTAL W version 1.6 (44). (A) Amino acid alignment of the LdMNPV protein with the enhancins of TnGV
(18), PuGV (32), and HaGV (32). Shaded boxes indicate identical residues conserved in the four enhancin proteins. Identical residues within the conserved zinc-binding
domain of all metalloproteases are in black boxes. (B) Schematic showing the percent amino acid identity (boxed numbers) within regions of the different enhancin
proteins. Regions exhibiting the greatest amino acid identity are shaded. LdMNPV enhancin is compared to the three GV proteins, while TnGV and PuGV enhancins
are compared with the HaGV protein.
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the enhancin protein itself. No radiolabeled bands were de-
tected for the parent plasmid pBluescript SK1 (Fig. 4).
Temporal analysis and primer extension mapping of the
enhancin transcripts. A 30-base oligonucleotide complemen-
tary to nucleotide positions 939 to 968 (Fig. 2) was used as a
strand-specific probe to characterize the temporal expression
of the LdMNPV enhancin gene. The enhancin gene is tran-
scribed primarily as a 3.5-kb transcript at late times, 48 and
72 h p.i. (Fig. 5). Two smaller RNA species (1.2 and 1.5 kb)
also appear to be expressed at these times, although at lower
levels. The gene does not seem to be transcribed at a high level,
or else the transcripts are not very stable, since the blot shown
in Fig. 5 contained 150 mg of RNA per lane and required a
long exposure (3 weeks) for detection of the transcripts. The
3.5-kb transcript is quite large, as the LdMNPV enhancin ORF
is only 2.3 kbp in length. In comparison, the TnGV enhancin
gene is expressed as two late transcripts, 2.7 and 3.3 kb in
length, in closer agreement with the size of the 2.7-kbp en-
hancin ORF in this virus (18).
To determine the transcriptional start site of the LdMNPV
enhancin transcripts, primer extension reactions were per-
formed with an 18-base oligonucleotide that is complementary
to nucleotides 132 to 149 within the enhancin ORF (Fig. 2).
Transcription initiates at the first A residue (position 38 in Fig.
2) within the consensus baculovirus late promoter sequence
TTAAG (Fig. 6). Since only one start site was detected, it is
possible that the large enhancin transcript initiates at this late
promoter upstream of the enhancin ORF, proceeds through
the enhancin and hrf-1 genes, and terminates at a potential
polyadenylation signal sequence (AATAAA) that has been
identified downstream of the hrf-1 gene (43). This polyadenyl-
ation signal sequence is 3.2 kbp downstream of the enhancin
late promoter. Analysis of HaGV enhancin RNAs by RNase
protection assay also indicated that the HaGV enhancin gene
and the downstream ORF1 gene may be part of the same
bicistronic message (32) and therefore similar to enhancin gene
transcription in LdMNPV.
Construction of the enhancin::cat virus. Since purified en-
hancin can increase the potency of the AcMNPV (45), a virus
in which the LdMNPV enhancin gene was disrupted was con-
structed, in order to determine if the protein has an effect on
LdMNPV potency. Plasmid pDB108 has the 4.3-kbp BamHI/
EcoRI fragment (located at 64.5 to 68.8 kbp on the viral ge-
nome) containing approximately 1.1 kbp of the portion of
enhancin which encodes the N-terminal end (Fig. 7). It also
contains approximately 3.2 kbp of upstream sequence and has
an SstI site 223 bp downstream of the enhancin ATG start
codon (Fig. 2). The insert used to disrupt the gene was a
fragment containing the cat gene that was isolated on a 0.7-kbp
SstI cassette from pDB4 (8). The promoter- and terminatorless
cat gene was cloned into the SstI site within the enhancin gene
to generate pDB159. This construct has the cat gene inserted
at codon 76 in the noncoding orientation with respect to the
enhancin ORF (Fig. 7). Since the cat gene is not translationally
fused and in the opposite direction to the enhancin ORF, it can
be used only as a marker to identify the recombinant virus
(through hybridization) and not for studies of gene expression
from the enhancin promoter. Analysis of the DNA sequence of
the insert predicts that a small transcript (approximately 454
FIG. 4. SDS-PAGE analysis after expression of enhancin under the control
of the T7 promoter. Shown is an autoradiograph of enhancin expressed in a
rabbit reticulocyte transcription and translation system and labeled with
[35S]Met. Lane 1, control plasmid, pBluescript SK1; lane 2, pDB126 expressing
enhancin. Molecular mass standards are indicated to the left, and the position of
the enhancin protein is indicated to the right.
FIG. 5. Temporal analysis of the LdMNPV enhancin transcripts. L. dispar
652Y cells were infected with LdMNPV isolate A21-MPV, and cytoplasmic RNA
was isolated at the times indicated. RNA (150 mg) was separated by formalde-
hyde-agarose gel electrophoresis, blotted, and probed with a strand-specific
oligonucleotide complementary to positions 939 to 968 in the enhancin ORF
(Fig. 2). RNA from uninfected cells was used as a control (lane C). RNA size
standards are indicated on the left, and the sizes of the transcripts are indicated
on the right.
FIG. 6. Determination of the 59 ends of the enhancin transcripts. Primer
extension analysis was performed for enhancin RNAs isolated at 48 and 72 h p.i.
RNA (40 mg) was incubated with an end-labeled 18-bp primer that is comple-
mentary to the enhancin nucleotide sequence at positions 132 to 149 (Fig. 2). The
primer was extended with Moloney murine leukemia virus reverse transcriptase.
Extension products were fractionated by PAGE and visualized by autoradiogra-
phy. The sequencing ladder was generated with the same primer. The late
transcriptional start site is underlined. C, control.
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bp in length) could still be expressed that initiates at the en-
hancin late promoter and terminates at a consensus polyade-
nylation signal sequence present in the cat gene insert. A small
fusion protein containing the first 76 aa of enhancin and 9
additional aa (from the cat gene insert) could be expressed
from the enhancin promoter. This fusion protein does not
contain the zinc-binding domain and is most likely not active.
The mutant was constructed and verified by Southern blot
analysis with the 4.3-kbp BamHI/EcoRI fragment as a probe
(Fig. 8). Viral DNA from A21-MPV and the enhancin::cat virus
was isolated and restricted with both BamHI and EcoRI. In
Fig. 8, lane 1, (A21-MPV), only the 4.3-kbp BamHI/EcoRI frag-
ment hybridized with the probe, as expected. The enhancin::cat
virus (lane 2) has an additional EcoRI site at the start of the cat
gene; therefore, two fragments hybridized in this isolate: (i) a
0.9-kbp EcoRI fragment and (ii) a 4.1-kbp fragment from the
BamHI to the EcoRI site at the beginning of the cat gene (Fig.
8). This result confirms that the mutation was transferred to
the viral genome and that the enhancin ORF was disrupted
with the cat gene in this isolate.
Bioassay analysis of the enhancin::cat virus. Bioassays (diet
incorporation and droplet feeding) were conducted with L. dis-
par larvae infected with either A21-MPV or the enhancin::cat
virus. Both the diet incorporation and droplet feeding methods
revealed that inactivation of the enhancin gene resulted in a
drop in viral potency ranging from 1.4- to 4.0-fold as deter-
mined by Probit analysis (Table 1). Although it is hard to de-
termine the exact degree of the drop in potency due to the
close LC50s for both viruses, in all four bioassays the enhancin::
cat virus was less potent than A21-MPV. The fiducial limits of
the LC50s for A21-MPV and the enhancin::cat virus did not
overlap in the droplet feeding bioassay. The droplet feeding
bioassay was used to verify the results of the diet incorporation
bioassays since the former method is more accurate for close
LC50s and yields smaller standard deviations than the diet
incorporation method (22). The drop in potency in the four
FIG. 7. Construction of the enhancin::cat virus. The 4.3-kbp BamHI/EcoRI fragment (64.5 to 68.9 kbp on the viral genome) containing the N terminus-encoding
portion of the enhancin gene was cloned from LdMNPV isolate A21-MPV into pUC18 to generate pDB108. A 0.7-kbp SstI fragment containing the cat gene was cloned
into the SstI site within the enhancin gene to generate pDB159.
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bioassays was analyzed by the unpaired t test (P 5 0.0125) and
by analysis of variance (P , 0.05) and was found to be signif-
icant. In the droplet feeding method, the volume ingested by
neonate L. dispar larvae was determined to be 176.5 6 37.1 nl
(data not shown). Based on this volume, the 50% lethal doses
were 17.9 6 2.4 polyhedra per larva for the enhancin::cat virus
and 8.7 6 1.0 polyhedra per larva for A21-MPV. Analysis of
the time-mortality response showed similar killing speeds for
the two viruses (data not shown). Therefore, the enhancin
protein has an effect on the potency of the virus but not on the
killing speed of the virus.
Previously it was reported that LdMNPV is evolutionarily
more distant from AcMNPV than are other NPVs, based on
phylogenetic analysis of the known polyhedrin gene sequences
from several baculoviruses (48). The finding of an enhancin
gene in the LdMNPV supports the polyhedrin gene phylogeny.
In addition, the presence of the LdMNPV enhancin gene may
suggest that the LdMNPV is more closely related to the GVs
than is the AcMNPV. Since the LdMNPV has an additional 29
kbp of DNA that is not present in the AcMNPV, it is possible
that other homologous genes possessed by both the GVs and
the LdMNPV will be identified as more sequence data become
available.
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17. Häse, C. C., and R. A. Finkelstein. 1993. Bacterial extracellular zinc-con-
taining metalloproteases. Microbiol. Rev. 57:823–837.
18. Hashimoto, Y., B. G. Corsaro, and R. R. Granados. 1991. Location and
nucleotide sequence of the gene encoding the viral enhancing factor of the
Trichoplusia ni granulosis virus. J. Gen. Virol. 72:2645–2651.
19. Henikoff, S., and J. G. Henikoff. 1991. Automatic assembly of protein blocks
for database searching. Nucleic Acids Res. 19:6565–6572.
20. Hughes, P. R. 1990. ViStat: statistical package for the analysis of baculovirus
bioassay data. Boyce Thompson Institute at Cornell University, Ithaca, N.Y.
21. Hughes, P. R., N. A. M. van Beek, and H. A. Woods. 1986. A modified droplet
feeding method for rapid assay of Bacillus thuringiensis and baculoviruses in
noctuid larvae. J. Invertebr. Pathol. 48:187–192.
22. Hughes, P. R., and H. A. Woods. 1981. A synchronous peroral technique for
the bioassay of insect viruses. J. Invertebr. Pathol. 37:154–159.
23. Ignoffo, C. M. 1965. The nuclear-polyhedrosis virus of Heliothis zea (Boddie)
and Heliothis virescens (Fabricius). IV. Bioassay of virus activity. J. Invertebr.
Pathol. 7:315–319.
24. Jiang, W., and J. S. Bond. 1992. Families of metalloendopeptidases and their
relationships. FEBS Lett. 312:110–114.
25. Jongeneel, C. V., J. Bouvier, and A. Bairoch. 1989. A unique signature identifies
a family of zinc-dependent metallopeptidases. FEBS Lett. 242:211–214.
26. Kunimi, Y., and J. R. Fuxa. 1996. Volumes ingested by four species of
noctuids with reference to peroral droplet bioassay of baculoviruses. J. In-
vertebr. Pathol. 68:310–311.
27. Lepore, L. S., P. R. Roelvink, and R. R. Granados. 1996. Enhancin, the
granulosis virus protein that facilitates nucleopolyhedrovirus (NPV) infec-
tions, is a metalloprotease. J. Invertebr. Pathol. 68:131–140.
28. Mahmoudi, M., and V. K. Lin. 1989. Comparison of two different hybrid-
ization systems in Northern transfer analysis. BioTechniques 7:331–333.
29. McCarthy, W. J., T. F. Murphy, and W. Langridge. 1979. Characterization of
the DNA from the Lymantria dispar nuclear polyhedrosis virus. Virology
95:593–597.
30. Murphy, G. J. P., G. Murphy, and J. J. Reynolds. 1991. The origin of matrix
metalloproteinases and their familial relationships. FEBS Lett. 289:4–7.
31. Riegel, C. I., C. Lanner-Herrera, and J. M. Slavicek. 1994. Identification and
characterization of the ecdysteroid UDP-glucosyltransferase gene of the
Lymantria dispar multinucleocapsid nuclear polyhedrosis virus. J. Gen. Virol.
75:829–838.
32. Roelvink, P. W., B. G. Corsaro, and R. R. Granados. 1995. Characterization
of the Helicoverpa armigera and Pseudaletia unipuncta granulovirus enhancin
genes. J. Gen. Virol. 76:2693–2705.
33. Russell, R. M., J. L. Robertson, and N. E. Savin. 1977. POLO: a new
computer program for Probit analysis. Bull. Entomol. Soc. Am. 23:209–213.
34. Slavicek, J. M., N. Hayes-Plazolles, and M. E. Kelly. 1995. Rapid formation
of few polyhedra mutants of the Lymantria dispar multinucleocapsid nuclear
polyhedrosis virus during serial passage in cell culture. Biol. Control. 5:251–
261.
35. Slavicek, J. M., M. J. Mercer, M. E. Kelly, and N. Hayes-Plazolles. 1996.
Isolation of a baculovirus variant that exhibits enhanced polyhedra produc-
tion stability during serial passage in cell culture. J. Invertebr. Pathol. 67:
153–160.
36. Smith, I. R. L., N. A. M. van Beek, J. D. Podgwaite, and H. A. Wood. 1988.
Physical map and polyhedrin gene sequence of Lymantria dispar nuclear
polyhedrosis virus. Gene 71:97–105.
37. Tanada, Y. 1985. A synopsis of studies on the synergistic properties of an
insect baculovirus: a tribute to Edward A. Steinhaus. J. Invertebr. Pathol.
45:125–138.
38. Tanada, Y., and S. Hara. 1975. Enzyme synergistic for insect viruses. Nature
(London) 254:328–329.
39. Tanada, Y., R. T. Hess, and E. M. Omi. 1975. Invasion of a nuclear polyhe-
drosis virus in midgut of the armyworm, Pseudaletia unipuncta, and the
enhancement of a synergistic enzyme. J. Invertebr. Pathol. 26:99–104.
40. Tanada, Y., M. Himeno, and E. M. Omi. 1973. Isolation of a factor, from the
capsule of a granulosis virus, synergistic for a nuclear polyhedrosis virus of
the armyworm. J. Invertebr. Pathol. 21:31–90.
41. Tanada, Y., and T. Hukuhara. 1971. Enhanced infection of nuclear polyhe-
drosis virus in larvae of the armyworm, Pseudaletia unipuncta, by a factor in
the capsule of a granulosis virus. J. Invertebr. Pathol. 17:116–126.
42. Tanada, Y., H. Inoue, R. T. Hess, and E. M. Omi. 1980. Site of action of a
synergistic factor of a granulosis virus of the armyworm, Pseudaletia
unipuncta. J. Invertebr. Pathol. 35:249–255.
43. Thiem, S. M., X. Du, M. E. Quentin, and M. M. Berner. 1996. Identification
of a baculovirus gene that promotes Autographa californica nuclear polyhe-
drosis virus replication in a nonpermissive insect cell line. J. Virol. 70:2221–
2229.
44. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W:
improving the sensitivity of progressive multiple sequence alignment through
sequence weighting, positions-specific gap penalties, and weight matrix
choice. Nucleic Acids Res. 22:4673–4680.
45. Wang, P., D. A. Hammer, and R. R. Granados. 1994. Interaction of Tricho-
plusia ni granulosis virus-encoded enhancin with the midgut epithelium and
peritrophic membrane of four lepidopteran insects. J. Gen. Virol. 75:1961–
1967.
46. Wang, P., and R. R. Granados. 1997. An intestinal mucin is the target for a
baculovirus enhancin. Proc. Natl. Acad. Sci. USA 94:6977–6982.
47. Yamamoto, T., and Y. Tanada. 1980. Physiochemical properties and location
of capsule components, in particular the synergistic factor, in the occlusion
body of a granulosis virus of the armyworm, Pseudaletia unipuncta. Virology
107:434–440.
48. Zanotto, P. M. A., B. D. Kessing, and J. E. Maruniak. 1993. Phylogenetic
interrelationships among baculoviruses: evolutionary rates and host associ-
ations. J. Invertebr. Pathol. 62:147–164.
49. Zhu, Y., T. Hukuhara, and K. Tamura. 1989. Location of a synergistic factor
in the capsule of a granulosis virus of the armyworm, Pseudaletia unipuncta.
J. Invertebr. Pathol. 54:49–56.
8140 BISCHOFF AND SLAVICEK J. VIROL.
